Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2006 2
2009 2
2010 6
2011 3
2012 5
2013 1
2014 1
2015 1
2016 4
2017 4
2018 5
2019 6
2020 1
2021 7
2022 6
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Breast Tumor Metastasis and Its Microenvironment: It Takes Both Seed and Soil to Grow a Tumor and Target It for Treatment.
Bonni S, Brindley DN, Chamberlain MD, Daneshvar-Baghbadorani N, Freywald A, Hemmings DG, Hombach-Klonisch S, Klonisch T, Raouf A, Shemanko CS, Topolnitska D, Visser K, Vizeacoumar FJ, Wang E, Gibson SB. Bonni S, et al. Among authors: vizeacoumar fj. Cancers (Basel). 2024 Feb 23;16(5):911. doi: 10.3390/cancers16050911. Cancers (Basel). 2024. PMID: 38473273 Free PMC article. Review.
Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomas.
Köbel M, Yang RZ, Kang EY, Al-Shamma Z, Cook LS, Kinloch M, Carey MS, Hopkins L, Nelson GS, McManus KJ, Vizeacoumar FS, Vizeacoumar FJ, Freywald A, Fu Y, Reuss DE, Lee CH. Köbel M, et al. Among authors: vizeacoumar fj. Gynecol Oncol. 2023 Nov;178:80-88. doi: 10.1016/j.ygyno.2023.09.016. Epub 2023 Oct 9. Gynecol Oncol. 2023. PMID: 37820398
Integration of cancer-related genetic landscape of Eph receptors and ephrins with proteomics identifies a crosstalk between EPHB6 and EGFR.
Hanover G, Vizeacoumar FS, Banerjee SL, Nair R, Dahiya R, Osornio-Hernandez AI, Morales AM, Freywald T, Himanen JP, Toosi BM, Bisson N, Vizeacoumar FJ, Freywald A. Hanover G, et al. Among authors: vizeacoumar fj. Cell Rep. 2023 Jul 25;42(7):112670. doi: 10.1016/j.celrep.2023.112670. Epub 2023 Jun 30. Cell Rep. 2023. PMID: 37392382 Free article.
A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.
El Zawily A, Vizeacoumar FS, Dahiya R, Banerjee SL, Bhanumathy KK, Elhasasna H, Hanover G, Sharpe JC, Sanchez MG, Greidanus P, Stacey RG, Moon KM, Alexandrov I, Himanen JP, Nikolov DB, Fonge H, White AP, Foster LJ, Wang B, Toosi BM, Bisson N, Mirzabekov TA, Vizeacoumar FJ, Freywald A. El Zawily A, et al. Among authors: vizeacoumar fj. Clin Cancer Res. 2023 Jul 14;29(14):2686-2701. doi: 10.1158/1078-0432.CCR-22-2535. Clin Cancer Res. 2023. PMID: 36976175 Free PMC article.
A CRISPR Platform for Targeted In Vivo Screens.
Maranda V, Zhang Y, Vizeacoumar FS, Freywald A, Vizeacoumar FJ. Maranda V, et al. Among authors: vizeacoumar fj. Methods Mol Biol. 2023;2614:397-409. doi: 10.1007/978-1-0716-2914-7_24. Methods Mol Biol. 2023. PMID: 36587138
Activation of the Anaphase Promoting Complex Reverses Multiple Drug Resistant Cancer in a Canine Model of Multiple Drug Resistant Lymphoma.
Arnason TG, MacDonald-Dickinson V, Gaunt MC, Davies GF, Lobanova L, Trost B, Gillespie ZE, Waldner M, Baldwin P, Borrowman D, Marwood H, Vizeacoumar FS, Vizeacoumar FJ, Eskiw CH, Kusalik A, Harkness TAA. Arnason TG, et al. Among authors: vizeacoumar fj. Cancers (Basel). 2022 Aug 30;14(17):4215. doi: 10.3390/cancers14174215. Cancers (Basel). 2022. PMID: 36077749 Free PMC article.
61 results